The pituitary organizer is a domain within the ventral diencephalon that expresses Bmp4, Fgf8, and Fgf10, which induce the formation of the pituitary precursor, Rathke's pouch, from the oral ectoderm. The WNT signaling pathway regulates this pituitary organizer such that loss of Wnt5a leads to an expansion of the pituitary organizer and an enlargement of Rathke's pouch. WNT signaling is classified into canonical signaling, which is mediated by b-CATENIN, and noncanonical signaling, which operates independently of b-CATENIN. WNT5A is typically classified as a noncanonical WNT; however, other WNT family members are expressed in the ventral diencephalon and nuclear localized b-CATENIN is observed in the ventral diencephalon. Therefore, we sought to determine whether canonical WNT signaling is necessary for regulation of pituitary organizer function. Using a conditional loss-of-function approach, we deleted b-catenin within the mouse ventral diencephalon. Mutant embryos have a smaller Rathke's pouch, resulting from a reduced pituitary organizer, especially Fgf8. This result suggests that canonical WNT signaling promotes pituitary organizer function, instead of inhibiting it. To test this hypothesis, we stimulated canonical WNT signaling in the ventral diencephalon using an inducible gain-of-function allele of b-catenin and found that stimulating canonical WNT signaling expands the domain of Fgf8 and results in a dysmorphic Rathke's pouch. These results demonstrate that canonical WNT signaling in the ventral diencephalon is necessary for proper expression of pituitary organizer genes and suggests that a balance of both canonical and noncanonical WNT signaling is necessary to ensure proper formation of Rathke's pouch. (Endocrinology 158: 3339-3353, 2017) 
T he pituitary gland is an essential component of the endocrine system and regulates numerous physiological processes. Congenital defects that disrupt pituitary gland formation result in a range of diseases, including isolated growth hormone deficiency, combined pituitary hormone deficiency, and syndromic diseases, such as septo-optic dysplasia (SOD) (1) . SOD is a midline patterning defect that results in variable combinations of optic nerve hypoplasia, absent septum pellucidum, and hypopituitarism (2) . The pituitary gland is a midline structure derived from an evagination of the ventral diencephalon, which forms an infundibulum and the pituitary posterior lobe, and an invagination of the oral ectoderm, which will produce Rathke's pouch, the precursor to the pituitary anterior lobe. Patterning of the ventral diencephalon is important, not only for the formation of the posterior lobe itself, but also for generating an organizing center located in the infundibular region, which is necessary for induction of Rathke's pouch (3) . This pituitary organizer is characterized by expression of bone morphogenetic protein 4 (Bmp4), fibroblast growth factor 8 (Fgf8), and Fgf10 (4-6). Mutations in FGF8 cause SOD, demonstrating that disrupting pituitary organizer function can result in pituitary disease (7) .
Genetically engineered mouse models have demonstrated that ventral diencephalon patterning and pituitary organizer function is essential for proper induction of Rathke's pouch (3) . Bmp4 is considered the inductive factor for Rathke's pouch, because Bmp4 2/2 mice fail to form a pituitary placode or Rathke's pouch at embryonic day 9.5 (E9.5) (4). Mice homozygous null for the BMP4 inhibitor, NOGGIN, have an expansion of BMP signaling in the ventral diencephalon, which results in a dysmorphic Rathke's pouch with multiple invaginations (8) . Fgf10
2/2
mice initially form Rathke's pouch, but it is lost through apoptosis (9) . Nkx2.1 is expressed in the ventral diencephalon, and Nkx2.1 2/2 mice also lose Rathke's pouch through apoptosis, likely resulting from reduced expression of Fgf8 in the pituitary organizer (4) . Together, these results suggest that FGF signaling acts as a survival factor for the pituitary progenitors in Rathke's pouch and that the combined activity of the pituitary organizer factors is to ensure the proper induction and proliferation of the pituitary progenitors in Rathke's pouch. The WNT signaling pathway is necessary for proper patterning of the ventral diencephalon. Wnt5a 2/2 mice have an expanded domain of Bmp4 and Fgf10 and an enlarged and dysmorphic Rathke's pouch (10) . WNT5A typically activates noncanonical pathways, which operate independently of CTNNB1 (b-CATENIN), an intracellular mediator of canonical WNT signaling (11) . TCF7L1 and TCF7L2 (TCF3 and TCF4) are transcription factors that form a complex with b-CATENIN to activate transcription of WNT target genes. In the absence of nuclear b-CATENIN, TCF7L1 and TCF7L2 are transcriptional repressors (12, 13) . Both Tcf7l1 2/2 and Tcf7l2 2/2 embryos have enlarged pituitary glands resulting from a rostral expansion of the pituitary organizer (14, 15) . Mouse embryos that express a truncated form of TCF7L1 that lacks the b-CATENIN interacting domain do not have an enlarged pituitary gland or expansion of the pituitary organizer (15) . This result suggests that the repressive function of TCF7L1 and TCF7L2, and not canonical WNT signaling, is necessary to establish the rostral limit of the pituitary organizer. Wnt11 and Wnt16 are also expressed in the ventral diencephalon and typically activate noncanonical Wnt signaling pathways (10) . The accumulating data suggest that noncanonical Wnt signaling acts to establish the rostral limit of the pituitary organizer. However, nuclear localized b-CATENIN is observed in the ventral diencephalon, and WNT5A and WNT16 are known to activate canonical WNT signaling in certain contexts (14, 16, 17) . Therefore, we sought to determine whether canonical WNT signaling has a functional role in patterning the ventral diencephalon and pituitary organizer.
Methods

Mice
The institutional committee on the use and care of animals for the University of South Carolina approved all experiments using mice. The Tg(Nkx2-1-cre)2Sand (Nkx2.1-cre) and Ctnnb1 tm2Kem (b-cat fx/fx ) mice were obtained from Jackson Laboratory (Bar Harbor, ME). The mice were housed in specific pathogen-free conditions with automatic watering, ventilated cages, and fed without restriction. Genotyping of the mice was performed as previously reported (18) (19) (20) . Timing of embryonic development was initiated by observation of a copulation plug. Noon of the day the copulation plug was detected was established as E0.5. All tissues used for these experiments were chosen without regard for sex. At least four mutant embryos were examined for all experiments.
Histology, immunostaining, and terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling assay Embryos were dissected from pregnant mothers and fixed overnight in 4% paraformaldehyde in phosphate-buffered saline at 4°C. The embryos were subsequently washed in phosphate-buffered saline, dehydrated in a graded ethanol series, and processed for paraffin embedding before sectioning at 6 mm (21). Select sections chosen for histologic examination were stained with hematoxylin and eosin (21) .
Information on the antibodies, including dilutions and sources, used for immunostaining is listed in Table 1 . Immunostaining for LHX3 was performed as previously reported (14, 22) . Tissues were blocked with blocking reagents from the M.O.M. kit (Vector Laboratories, Burlingame, CA) as recommended by the manufacturer. Biotin-conjugated mouse secondary antibody (Vector Laboratories) was incubated for 30 minutes at room temperature, followed by streptavidinconjugated horseradish peroxidase (TSA Kit no. 22; Thermo Fisher Scientific, Waltham, MA) diluted 1:100 for 30 minutes at room temperature and then tyramide signal amplification with Alexa Fluor 488 (TSA Kit no. 22; Thermo Fisher Scientific) for 3 minutes. Immunostaining for SHH was performed as previously reported (8) . Tissues were blocked with the blocking reagent from TSA kit no. 22 (Thermo Fisher Scientific). Biotinconjugated anti-goat IgG (Thermo Fisher Scientific) secondary antibody was incubated on the tissues for 30 minutes at room temperature, followed by streptavidin-conjugated horseradish peroxidase (30 minutes at room temperature), and then tyramide signal amplification with Alexa Fluor 594 (TSA Kit no. 25, Thermo Fisher Scientific) for 3 minutes. Immunostaining for the anterior pituitary hormones was performed as previously described using antibodies from the National Hormone and Pituitary Program, National Institute of Diabetes and Digestive and Kidney Diseases (Torrance, CA) (23) . Species-appropriate Alexa Fluor 594-conjugated secondary antibody was used (Thermo Fisher Scientific). All slides were counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI) for 5 minutes before being mounted in fluorescence mounting media. Immunostaining for Ki67 was performed after a 10-minute 10-mM citric acid, pH 6.0, boil and blocking with the TSA block. Directly conjugated Alexa Fluor 594 goat anti-rabbit IgG (Thermo Fisher Scientific) was used as the secondary antibody. All immunostained slides were counterstained with DAPI for 5 minutes before being mounted in fluorescence mounting media. Apoptosis was detected using the DeadEnd Fluorometric deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) System (Promega, Madison, WI). TUNEL labeling was performed in accordance with the published protocol, and the cell nuclei were counterstained with DAPI for 5 minutes. The slides were mounted using fluorescence mounting media.
RNAscope in situ hybridization
Tissue sections cut at 6 mm thickness were processed for messenger RNA (mRNA) in situ detection using the RNAscope 2.5 HD reagent kit-BROWN (Advanced Cell Diagnostics, Newark, CA), according to the manufacturer's recommendations. In brief, the sections were deparaffinized, incubated with hydrogen peroxide for 10 minutes at room temperature, boiled with target retrieval for 15 minutes, and treated with protease at 40°C for 20 minutes. The RNAscope probes used were Bmp4, Fgf8, and Fgf10 (Advanced Cell Diagnostics). All tissues were tested with both positive and negative control probes supplied by the manufacturer. Sections were counterstained with hematoxylin according to the manufacturer's recommendations.
Results
Canonical WNT signaling is mediated by b-CATENIN, and Ctnnb1 homozygous null embryos (b-cat 2/2 ) are embryonic-lethal at gastrulation (24) . Therefore, we sought to remove b-catenin in the ventral diencephalon using a conditional null approach. The Tg(Nkx2-1-cre)2Sand (Nkx2.1-cre) results in cre recombinase activity in the ventral diencephalon and lungs and has been used previously to generate conditional null alleles in the infundibular region of the ventral diencephalon (18, 25 . Because of the continued, although reduced, presence of b-catenin mRNA and protein after cre-mediated deletion, we assumed that any phenotypes produced in Nkx2.1-cre; b-cat fx/fx embryos were a result of reduced activity of b-catenin and not a complete loss of function.
In both the b-CATENIN immunostaining and the RNAscope assays, the size of Rathke's pouch appeared smaller in the Nkx2.1-cre; b-cat fx/fx embryos compared with their wild-type littermates. Rathke's pouch contains the pituitary progenitors that will differentiate to form the hormone-secreting cell types of the pituitary anterior and intermediate lobes (28, 29) . LHX3 expression at E10.5 identifies these pituitary progenitors from neighboring oral ectoderm cells, which will be excluded from Rathke's pouch [ Fig. 1 Nkx2.1cre; b-cat fx/fx mutants is reduced compared with wild-type, confirming the smaller size of Rathke's pouch and the reduction in pituitary progenitors. At E12.5, Rathke's pouch has separated from the oral ectoderm in wild-type embryos [ Fig. 1(g) ]. In Nkx2.1-cre; b-cat fx/fx mutants, Rathke's pouch has also separated from the oral ectoderm, but the pituitary precursor remains smaller in size as assayed by LHX3 immunostaining [ Fig. 1(h) ]. At E10.5, the evagination of the infundibulum begins in wild-type embryos and eventually projects down the caudal side of Rathke's pouch Differentiation of pituitary cell types is traditionally assayed by immunostaining for hormones expressed by each cell type: proopiomelanocortin (POMC), the precursor polypeptide for adrenocorticotropic hormone in corticotropes and melanocyte-stimulating hormone in melanotropes, growth hormone (GH) in somatotropes, thyroid-stimulating hormone (TSH) in thyrotropes, luteinizing hormone (LH) in gonadotropes, and prolactin in lactotropes. All these hormones are detectable at E18.5, except for prolactin, which is not readily detectable until postnatally (23, 30) . POMC, GH, TSH, and LH are all detectable in Nkx2.1-cre; b-cat fx/fx mutant embryos at E18.5 ( Fig. 2) , demonstrating that patterning and differentiation of the pituitary progenitors occurs in the Nkx2.1-cre; b-cat fx/fx mutant pituitary, despite the smaller size.
(e)] (22). LHX3 immunostaining in
The small size of Rathke's pouch in Nkx2.1-cre; b-cat fx/fx mutant embryos suggests that the activity of the pituitary organizer is reduced. We used RNAscope to assay the expression of Bmp4, Fgf8, and Fgf10 in the ventral diencephalon. Bmp4 is expressed in the infundibular region of the ventral diencephalon of wild-type embryos, and scattered expression is also observed in the pituitary progenitors of Rathke's pouch, which, to the best of our knowledge, has not been previously reported [ Fig. 3(a) ]. Bmp4 is expressed in the tissue of the ventral diencephalon in Nkx2.1-cre; b-cat fx/fx mutant embryos; however, the signal intensity appears reduced [ Fig. 3(b) ]. Fgf8 and Fgf10 are also expressed in the infundibular region of wild-type embryos [ Fig. 3(c) and 3(e) ]. Nkx2.1-cre; Fgf8 expression [ Fig. 3(d) ], and the domain of Fgf10 expression is reduced [ Fig. 3(f) ]. SHH is expressed in the ventral diencephalon in a domain rostral to the infundibular region [ Fig. 3(g) ]. SHH expression in Nkx2.1-cre; b-cat fx/fx mutants did not shift caudally but maintained its boundary on the rostral side of Rathke's pouch. These results suggest that b-catenin is required in the ventral diencephalon to maintain the expression of Bmp4, Fgf8, and Fgf10 in the pituitary organizer but not to inhibit Shh transcription.
Fgf8 and Fgf10 in the ventral diencephalon promote the survival of pituitary progenitors in Rathke's pouch (4, 9) . Because these signaling factors are reduced in the ventral diencephalon, we reasoned that proliferation of the pituitary progenitors might be reduced and apoptosis increased in Nkx2.1-cre; b-cat fx/fx mutants. Using near adjacent sections from single embryos, we identified the pituitary progenitors with LHX3 immunostaining and assayed proliferation with Ki67 and apoptosis with a TUNEL assay (Fig. 4) . As Rathke's pouch separates from the oral ectoderm, the pituitary progenitors are highly proliferative and do not undergo apoptosis [ Fig. 4(c) and (e)]. A domain of cell death is observed in the oral ectoderm, ventral to Rathke's pouch. In Nkx2.1-cre; b-cat fx/fx mutants, pituitary progenitors contained in Rathke's pouch are also highly proliferative [ Fig. 4(d)] and are not significantly different from wild-type (data not shown). Nkx2.1-cre; b-cat fx/fx mutants do have an increase in apoptotic cells, but they are not contained within Rathke's pouch. Instead, they are located ventral to the LHX3 domain, between the pituitary progenitors and the oral ectoderm. The morphology of these cells suggests that they are oral ectoderm that more evident at E12.5 and can encompass most of the oral ectoderm [ Fig. 5(f) ]. In addition, the pituitary progenitors fail to separate from the oral ectoderm and form Rathke's pouch. The ventral diencephalon of Nkx2.1-cre; b-cat GOF/+ mutant embryos is thicker than that of their wild-type littermates and fails to form an infundibulum [ Fig. 5(e) and 5(f) ]. In normal embryos at E16.5, the sphenoid bone forms ventral to the pituitary gland, separating the pituitary gland from the oral ectoderm [ Fig. 5(g) ]. In Nkx2.1-cre; b-cat GOF/+ mutant embryos, the typical location of the pituitary gland between the forebrain and hindbrain is filled with mesenchyme [ Fig. 5(h) and 5(i) ]. Given the failure to separate the pituitary progenitors from the oral ectoderm at E12.5, the thickened tissue in the oral cavity might be an ectopic pituitary anterior lobe [ Fig. 5 (h) and 5(j)]. To confirm the identity of this thickened tissue as pituitary, we performed immunostaining for the pituitary hormones at E18.5. POMC, GH, TSH, and LH were all detected in the thickened tissue in the oral cavity, confirming that this tissue is an ectopic pituitary gland and that the pituitary progenitors are able to undergo cell specification despite their ectopic location in the oral ectoderm (Fig. 6) .
The closure of the secondary palate separates the nasal cavity from the oral cavity. At E16.5, the closed secondary palate is visible in normal embryos [ Fig. 5(g) ].
Nkx2.1-cre; b-cat GOF/+ mutant embryos do not have a closed secondary palate beneath the ectopic pituitary gland [ Fig. 5(h) ]. Examination of more lateral sections indicated that the palatal shelves form but fail to close in Nkx2.1-cre; b-cat GOF/+ mutant embryos (Supplemental Fig. 1) .
The dysmorphic Rathke's pouch of Nkx2.1-cre; b-cat GOF/+ mutant embryos is similar to that of other mouse models with enlarged and dysmorphic pituitary glands that have a rostral shift in the pituitary organizer (3). We used RNAscope to assay the expression of Bmp4, Fgf8, and Fgf10 in wild-type and Nkx2.1-cre; b-cat GOF/+ embryos at E10.5 (Fig. 7) . As expected Fgf8 expression was expanded in Nkx2.1-cre; b-cat GOF/+ mutant embryos [ Fig. 7(b) ], and the thickened oral ectoderm corresponded to the overlying domain of Fgf8 expression. However, Fgf10 and Bmp4 expression were both reduced in Nkx2.1-cre; b-cat GOF/+ mutant embryos [ Fig. 7 (c)-7(f)]. The expression of Fgf10 was also limited to small domains that appear discrete from the rest of the neural ectoderm [ Fig. 7(d) ]. In one-half of the embryos examined, Fgf10-expressing cells appeared to be extruded from the neural ectoderm. In colon cancer and Drosophila wing imaginal discs, differential levels of canonical WNT signaling can cause an extrusion response from the epithelium that results in cyst formation (31) .
We examined the ventral diencephalon of b-CATENIN immunostained Nkx2.1-cre; b-cat GOF/+ mutant embryos [ Fig. 5(b) ] and noted small domains with lower levels of b-CATENIN that resembled the Fgf10 RNAscope domains. To determine whether the Fgf10 expression domain and the domain of reduced b-CATENIN expression coincided, we immunostained the section adjacent to the section used in the Fgf10 RNAscope assay for b-CATENIN and found that the extruded domain also had reduced b-CATENIN expression compared with the rest of the ventral diencephalon [ Fig. 7(d, inset) ].
The domain of SHH rostral to the pituitary organizer was examined using immunostaining, and Nkx2.1-cre; b-cat GOF/+ mutant embryos lost expression of SHH in this domain [ Fig. 7(h) ]. These results demonstrate that activation of canonical WNT signaling in the ventral diencephalon has differential effects on the pituitary organizer. Excess canonical WNT signaling ablates the SHH expression domain completely, preferentially expands Fgf8 expression, and reduces Fgf10 and Bmp4 expression.
Discussion
We have demonstrated that b-catenin is necessary for maintaining the pituitary organizer in the ventral diencephalon and that stimulation of canonical WNT signaling is sufficient for expanding Fgf8 expression and pituitary organizer activity and decreasing SHH expression. Numerous studies have demonstrated that proper patterning of the ventral diencephalon is necessary to generate a pituitary organizer, including the expression of Bmp4, Fgf8, and Fgf10, which will induce the formation of pituitary progenitors in Rathke's pouch (3) . WNT signaling in the ventral diencephalon is a key contributor in patterning the ventral diencephalon. The WNT signaling components Wnt5a, Tcf7l1, and Tcf7l2 are all necessary for establishing the rostral limit of the pituitary organizer, as evidenced by the expanded pituitary organizer in Wnt5a 2/2 , Tcf7l1 2/2 , and Tcf7l2 (10) . In heart development, WNT5A and WNT11 together stimulate noncanonical WNT signaling and inhibit canonical WNT signaling, thus promoting secondary heart field development (32) . However, WNT5A can stimulate canonical WNT signaling in specific contexts, including in the meninges under the calvaria, where WNT5A overexpression stimulates canonical WNT signaling, leading to reduced calvarial bone density (16) . WNT16 also functions in bone formation and is expressed in osteoblasts, where it stimulates both canonical and noncanonical WNT pathways simultaneously, leading to inhibition of osteoclasts and promotion of bone density (17) . Determining how canonical and noncanonical WNT signaling is integrated in the ventral diencephalon requires continued research, including expression studies of WNT co-receptors, such as LRP5, LRP6, RYK, and ROR2, which are instrumental in activating differing branches of the WNT signaling cascade (33) .
Previously, we observed an expanded pituitary organizer when b-catenin was deleted using the Wnt1-cre, which is expressed in the midbrain and neural crest cells (34) . We observed ectopic activity of the Wnt1-cre in the ventral diencephalon but determined that the level of ectopic cre activity was insufficient to cause an expanded pituitary organizer. We concluded that the expanded pituitary organizer in Wnt1-cre; b-cat fx/fx embryos was caused by a shift in patterning of the ventral diencephalon, resulting from loss of b-catenin in the midbrain. Our current results support this conclusion, as reduction of b-catenin in the ventral diencephalon resulted in a reduction of the pituitary organizer and not an expansion.
The differential effect of canonical WNT signaling on the individual pituitary organizer factors, especially in the gain-of-function studies, was a surprising outcome of the present study. Stimulating canonical WNT signaling resulted in an expansion of Fgf8 expression but a reduction of Bmp4 and Fgf10. This transcriptional activation of Fgf8 in response to canonical WNT signaling is similar to the results using the same b-catenin gain-offunction allele and the FoxG1-cre, which resulted in increased Fgf8 transcription in the anterior neural ridge where FoxG1 is expressed (26 leaving open the possibility that only one of these FGFs is the survival factor. The restriction of Fgf10 expression to small "blebs" of neuroectoderm in the Nkx2.1-cre; b-cat GOF/+ mutant embryos implies that Fgf10 might have a function discrete from that of Fgf8 within the infundibular region in regulating cell shape or fate. These blebs of Fgf10 expression might also be related to differential levels of canonical WNT signaling in the neural ectoderm. b-CATENIN immunostaining of Nkx2.1-cre; b-cat GOF/+ mutant embryos revealed small domains in the ventral diencephalon with less b-CATENIN expression, suggesting the presence of a mechanism that prevents the excessive accumulation of b-CATENIN in these cells. The domains of lower b-CATENIN expression and Fgf10 expression in the ventral diencephalon appear to overlap. Heterogeneous WNT signaling in the colon and Drosophila wing imaginal disc results in clonal separation and cyst formation (31) , suggesting that the "blebs" observed in Nkx2.1-cre; b-cat GOF/+ mutant embryos might occur through a similar mechanism.
The dysmorphic Rathke's pouch in the Nkx2. (38, 39) . Tissue specific deletions of Bmp4, Fgf8, and Fgf10 in the ventral diencephalon are necessary to determine the individual functions for each of these morphogenetic proteins in the pituitary organizer. SHH signaling is critical for the proper formation of midline structures, and mutations that reduce SHH signaling can generate a range of midline defects, including holoprosencephaly, cyclopia, cleft lip, and single incisor, depending on the severity of the mutation (40, 41) . Shh is also expressed in the pharyngeal endoderm, where it is required for growth of the palatal shelves (42) . Several explanations are possible for the cleft palate we observed in the Nkx2.1-cre; b-cat GOF/+ mutant embryos ( Fig. 5; Supplemental Fig. 1 ). The loss of SHH in the ventral diencephalon might disrupt midline patterning or the cleft palate might be caused by the presence of the ectopic pituitary disrupting normal signaling in the oral cavity. Alternatively, Nkx2.1-cre is expressed in the pharyngeal endoderm that forms the thyroid gland (18) , and stimulating canonical WNT signaling in the pharyngeal region might affect palatal shelf formation.
SOD is a variable condition characterized by optic nerve hypoplasia, telencephalic midline defects, pituitary hypoplasia, and pituitary hormone deficiency. Familial cases of SOD are caused by mutations in HESX1, SOX2, SOX3, OTX2, FGF8, and TAX1BP3 (7, 43, 44) . Our data suggest that mutations in components of the canonical WNT signaling pathway might also cause SOD through a decrease in FGF8 expression in the ventral diencephalon. TAX1BP3 is a PDZ-containing protein with unknown function in pituitary development. TAX1BP3 is implicated in both canonical and noncanonical WNT signaling through direct binding to b-CATENIN and RHOTEKIN, with the latter involved in noncanonical WNT signaling (45, 46) . Initial experiments suggested that TAX1BP3 inhibits canonical WNT signaling in cell culture and that both overexpression and knockdown studies result in disrupted convergent extension movements in zebrafish embryos, which are mediated by noncanonical WNT signaling (46, 47) . An analysis of TAX1BP3 molecular function in the ventral diencephalon is necessary to determine how TAX1BP3 mutations result in hypopituitarism and midline defects. Our results suggest two possibilities. If TAX1BP3 acts to inhibit canonical WNT signaling in the ventral diencephalon, an expansion of canonical WNT signaling would expand FGF8 and decrease SHH signaling, which is critical for patterning the midline (48) . Alternatively, if TAX1BP3 promotes noncanonical WNT signaling in the ventral diencephalon, a reduction in noncanonical WNT signal would expand the pituitary organizer, resulting in decreased SHH signaling. Regardless of the molecular mechanism for TAX1PB3, screening of patients with SOD for mutations in WNT signaling components might reveal additional genetic lesions that reduce either FGF8 or SHH function in the ventral diencephalon, resulting in midline defects and hypopituitarism.
